Active, not recruitingNCT06480773
Kaposi Sarcoma Chemotherapy and Research (KS-CARE)
Studying HIV-associated cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Principal Investigator
- Dirk Dittmer, PhDUNC Lineberger Comprehensive Cancer Center
- Intervention
- standard of care chemotherapy(drug)
- Enrollment
- 127 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (2)
- UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi
- Stellenbosch University and Tygerberg Hospital, Cape Town, Stellenbosch, South Africa
Collaborators
National Center for Advancing Translational Sciences (NCATS) · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06480773 on ClinicalTrials.govOther trials for HIV-associated cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07308886Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)National Cancer Institute (NCI)
- RECRUITINGNANCT05561595Transdiagnostic Intervention to Reduce Internalized Health-Related StigmaUniversity of Florida
- RECRUITINGPHASE1, PHASE2NCT06343311T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)Estrella Biopharma, Inc.
- RECRUITINGPHASE1NCT04902443Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVNational Cancer Institute (NCI)
- RECRUITINGPHASE1, PHASE2NCT04941274Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi SarcomaNational Cancer Institute (NCI)